Analyst Initiates Coverage On Accolade, Says ‘Differentiated In Growing Market’
Raymond James initiated coverage on Accolade Inc (NASDAQ:ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected…
Guggenheim Initiates Darden Restaurants With A Buy: ‘Good Times, Great Stock, Olive Garden’
Analysts at Guggenheim Partners had not rescinded their initial outlook that the restaurant industry would struggle to structurally grow margins as long as the unemployment rate stayed below 4%.
But the firm said Thursday it was betting on one group to outperform.
‘The Year Of The Efficient Rabbit’: Why Analysts Are Raising Their Price Targets On Meta Platforms (Including One Doubling The PT)
Social media and metaverse company Meta Platforms Inc (NASDAQ: META) reported fourth quarter financial results and first quarter guidance af
How Match Group Became A ‘Show Me Story’ Following Layoffs, Subscriber Exodus
Match Group Inc (NASDAQ: MTCH) joined the tech majors to announce layoff plans that reduce its global workforce by 8%.
Jim Cramer Says Mistaken Selling Creates Opportunities To Buy Dips: Bears ‘Still Don’t Know What Hit Them’
Prominent market commentator Jim Cramer asked investors not to get swayed by market bears and use their missteps to boost their own portfolios.
Western Digital Gross Margins Vulnerable To Pricing, Minimal Cost-Down, Analyst Says
Mizuho analyst Vijay Rakesh maintained Western Digital Corp (NASDAQ:WDC) with a Neutral and lowered the price target from $38 to $35. WDC…
Being Cautious On Regulatory/Commercial Path, This Analyst Initiates Coverage On Verve Therapeutics
Cantor Fitzgerald initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV) with a Neutral rating and a price target of $21. The analyst says…
PayPal’s Downsizing Was Needed For Leaner Cost Structure, Analyst Says
Mizuho analyst Dan Dolev reiterated Buy on PayPal Holdings, Inc (NASDAQ:PYPL) with a price target of $105. PYPL shared plans to reduce…
Alibaba A Top Pick As Logistic Disruption Ease, Lift Sector Valuations, Analyst Says
Benchmark analyst Fawne Jiang reiterated a Buy on Alibaba Group Holding Limited (NYSE: BABA)